Related Posts Plugin for WordPress, Blogger...

Liraglutide Reduces Heart Disease In People with Type 2 Diabetes

>> Saturday, March 5, 2016



BIG news in the diabetes world was released on Friday - for the first time, a medication in the class called GLP-1 receptor agonists, called liraglutide (trade name Victoza), has been shown to reduce cardiovascular events in people with type 2 diabetes.

The LEADER trial enrolled over 9000 people with type 2 diabetes, who were at high risk of cardiovascular disease, and randomized them to receive either Victoza vs placebo with usual standard of care.

They found that Victoza was better than placebo to reduce the combination of death from cardiovascular disease, non-fatal heart attack and non-fatal stroke. A reduction in all three of these components contributed to the benefit that was seen.   The numbers and details are not yet available - we'll have to wait until the American Diabetes Association meeting in June to find out more.

Here's why this is ground-breaking news: 

We have long been uncertain whether we are actually preventing cardiovascular disease by treating diabetes - we know that the higher sugars are, the higher the risk of heart disease, but it has been evasive to actually prove that lowering blood sugars prevents heart disease. The next question is whether some medications to treat type 2 diabetes could be better (or worse) than others to protect from heart disease.  LEADER has now shown us that treating type 2 diabetes with liraglutide does indeed protect patients from cardiovascular events.

Within the GLP1 receptor agonist group of medications, a study of lixisenatide (called the ELIXA study) showed that it did not increase the risk of cardiovascular events, but it didn't prevent them either.  Studies of the other GLP1 receptor agonists available are currently underway.

As far as other type 2 diabetes medications go, the only other medication that has clearly been shown to reduce cardiovascular disease is empagliflozin, which you can read more about here and here.  Metformin, which is the #1 treatment advised for type 2 diabetes worldwide, has some weak evidence that it prevents cardiovascular events as well.

We will be waiting in anticipation for more details from the LEADER trial in June!


Disclaimer: I have been involved in research trials of liraglutide.  I receive honoraria as a continuing medical education speaker and consultant from the makers of liraglutide (Novo Nordisk). I am involved in research of medications similar to liraglutide for the treatment of type 2 diabetes.



Follow me on twitter! @drsuepedersen


www.drsue.ca © 2016

Read more...

The Legacy Effect 30 Years Later - Good Control of Diabetes Prevents Heart Disease

>> Wednesday, February 24, 2016


A lot of people with diabetes wonder why their doctors and diabetes educators are seemingly obsessed with keeping blood sugars as close to normal as we can.  After all, blood sugars that are only mildly elevated usually don't come with much in the way of symptoms.

The point to keeping sugars as well controlled as possible is to prevent complications of diabetes developing over time - this includes damage to the eyes, heart, kidneys, and nerves in the feet and elsewhere in the body.

And - a new paper published has now shown us that the benefit of good control of diabetes to prevent cardiovascular disease persists for at least thirty years!

The study, which was recently published in the journal Diabetes Care, evaluated patients 30 years after their initial participation in the famed (well, famous in the diabetes world anyway) DCCT trial.  This was a clinical trial that enrolled 1,441 patients with type 1 diabetes, and assigned them to receive either more intense, or less intense, control of their blood sugars for a mean of 6.5 years.

During the 30 years of follow up, they found that the people who were in the tightly controlled group 30 years previously had a 30% reduction in the risk of developing cardiovascular disease, and a 32% reduction in the likelihood of having a heart attack, stroke, or dying from a cardiovascular cause, compared to those who were in the less tightly controlled group.  The tighter blood sugar control during the time of the original 6.5 year study was statistically responsible for all of the difference in cardiovascular disease between the two groups.

This data really impresses upon us the power of what we call the 'legacy effect' - good control of diabetes early on prevents complications later in life.  (Note: there is a similar trial in type 2 diabetics called the UKPDS study, which also showed that the legacy effect exists 10 years later.)

I think it is challenging for anyone to look forward 30 years into the future, and think about the importance of what we are doing now to our future self.  If you think about it, we actually spend a lot of our lives planning for our 30+ year future self.  Take financial planning, for example - most of us structure our home purchases, savings structures, and investments with the goal of planning for the distant future.  As I see it, planning for our health in the future is no different - and for people with type 1 diabetes, we now have very long term data to back this up.


Follow me on twitter! @drsuepedersen

www.drsue.ca © 2016

Read more...

Natural Remedy Star Fruit Causes Kidney Damage

>> Wednesday, February 17, 2016




It is often in my day that people tell me that they are taking natural remedies for any number of medical conditions - for aches and pains, diabetes, obesity, cancer prevention... the list goes on.  The thinking that often underlies the decision to take these remedies is that they are natural, so how could they possibly be harmful?

I worry about my patients taking natural or naturopathic products, because rigorous clinical trials are not done to show benefit, nor (most concerning) to understand potential harms.  So, when I came across two very serious case reports of kidney damage from the seemingly innocent star fruit, I wanted to share it to illustrate the potential dangers of natural remedies.

Star fruit comes from a tree native to India and southeast Asia.  In addition to eating them as a fruit (I've enjoyed them myself on occasion while traveling to these areas), they are also touted as a herbal remedy for various ailments (including diabetes) in these countries.

Recently, two cases of star fruit toxicity were published.  One case was that of a woman with type 2 diabetes who consumed 200 mL of star fruit juice (less than a cup) from six star fruits, which resulted in kidney failure due to an inflammatory reaction in the kidneys (acute interstitial nephritis) caused by the high oxalate content of star fruit.  Thankfully, with medical treatment, her kidneys recovered.

The second case was that of a man with a history of moderate kidney dysfunction, who developed kidney failure after eating four star fruits over four days.  Thankfully, he also recovered after about 2 weeks.

In addition, like the grapefruit, star fruit also inhibits a group of liver enzymes (cytochrome P450 isoforms) which are important for metabolism of medications such as statins (cholesterol medications).  This is why it is advised for patients on statins not to eat grapefruit - star fruit should be included in this counselling as well.

So, take these cases into consideration the next time you think about reaching for a herbal remedy - remember that we simply do not know enough about these remedies to know if they are safe.

As a patient, be sure to tell your doctor about any natural remedies you are taking.

As a health care professional - remember to ask.


Follow me on twitter! @drsuepedersen

www.drsue.ca © 2016

Read more...

PREdiabetes May Cause Kidney Damage

>> Sunday, January 17, 2016








In our quest to control blood sugars of people who have diabetes, one of the 'small blood vessel' complications of diabetes that we are trying to prevent is damage to the kidneys.  For people who have prediabetes, it has generally been thought that they do not have an increased risk of small vessel disease.  However, there is mounting evidence that prediabetes may in fact cause small vessel damage; a new study suggests that prediabetes may in fact cause kidney damage.

First, let's talk about what we mean when we say 'prediabetes'.  Diabetes and prediabetes are defined on the basis of how high blood sugars are.   Quite simply, prediabetic blood sugars are lower than diabetic range blood sugars, but higher than normal blood sugars.  For the exact blood sugar definitions in Canada, please see Table 2 (diabetes) and Table 4 (prediabetes) here.

A study suggesting that prediabetes causes kidney damage was published in the American Journal of Kidney Diseases.  The study was a prospective cohort study that followed 1,261 people without diabetes between the ages of 50-62 for a median time of 5.6 years.  Participants who had prediabetes at the start of the study were at nearly 2 times higher risk of having hyperfiltration (an early manifestation of diabetic kidney disease), and at 1.8 times higher risk of having higher-normal albumin levels in their urine, compared to those with normal blood sugars (albumin in the urine is also a diabetes-related kidney complication). These changes were seen independently of other risk factors such as blood pressure at baseline, and independent of changes in blood pressure medications.

That prediabetes can cause complications before diabetes develops has a profound impact, in that 1 in 4 Canadian adults has diabetes or prediabetes, with most of those being prediabetic.  (In USA, 44% of American adults have diabetes or prediabetes).  Most people with prediabetes do not know that they have this condition, as there are usually no symptoms of this condition.

While the notion that prediabetes can cause small blood vessel complications is relatively new, it is known that prediabetes (especially impaired glucose tolerance) are at a substantially higher risk of developing BIG vessel complications (eg heart disease).

Knowing that prediabetes can cause organ damage makes two things very clear:

1.  We need to be checking for prediabetes in people who are at risk; and

2.   We need to aggressively prevent and treat prediabetes.


Follow me on twitter! @drsuepedersen

www.drsue.ca © 2016

Read more...

Part 2 - Why It Is So Hard To Avoid Weight Regain

>> Friday, December 11, 2015





In last week's post, I talked about the decrease in energy burn that happens with weight loss.  Today, let's focus on the other major driver of weight regain - the powerful changes in hormones that happen with weight loss, which drive us to eat more and regain the weight we worked so hard to lose.


In humans, there is only one hormone that is known to increase hunger, called ghrelin.  Interestingly, there are many hormones that signal satiety, telling us that we feel full.  Several hormones tell us we feel full in the short term (release 10-15 minutes into a meal), including hormones called GLP-1, cholecystokinin (CCK), PYY, oxyntomodulin, and others.  There are also hormones circulating that are long terms signals of fat and energy storage, which are also fullness hormones: leptin, which is made by fat cells, and insulin, which is made by the pancreas.  These hormones act in the hypothalamus in our brain to regulate when and how much we eat.  (there are also many emotional and social drivers of eating, called 'hedonic' mechanisms... stay tuned for more on this important factor another day :).


When we lose weight, leptin and insulin both drop precipitously, which result in a powerful drive to eat and regain the lost weight.  The short terms regulators of hunger and fullness are affected as well, including a decrease in GLP-1, PYY, and CCK, and an increase in ghrelin, all of which work in concert to beg our brains to eat more, eat more!  Studies have shown that even a year after weight loss, these hormone changes persist - an unrelenting drive to regain the lost weight.

So what can we do to combat these hormonal changes?  It's not easy - evolution has made it so to drive us HARD to look for food and eat during times of food scarcity.  Keeping the energy burn up with activity helps to offset the powerful hormonal drive to increase energy intake, but a whole lotta exercise can be 'cancelled out' by what we can eat in just a minute or two.  Fortunately, medications are now available or in development to combat these hormonal changes, which can help to maintain weight after weight loss.  The only medication along these lines available in Canada is called liraglutide or Saxenda, and it has been shown not only to help people to maintain an average 6% weight lost from diet and exercise, but actually helped people lose an additional 6% weight loss over a year on top of that (with the ever critical lifestyle changes continued throughout).


Disclaimer: I was involved in the research trials of liraglutide as an obesity treatment.  I receive honoraria as a continuing medical education speaker and consultant from the makers of liraglutide (Novo Nordisk). I am involved in research of medications similar to liraglutide for the treatment of obesity and type 2 diabetes.



Follow me on twitter! @drsuepedersen

www.drsue.ca © 2015 

Read more...

Why Is It So Hard To Avoid Weight Regain?

>> Saturday, December 5, 2015



One of the biggest challenges in successful weight management is prevention of weight regain after weight loss.   Studies show that most often, people regain weight after intentional weight loss, with many people regaining most or all of their lost weight over time (and then some, in some cases).

There are two major drivers of weight regain:

1.  Many powerful changes in hunger and fullness hormones happen with weight loss, which drive us to eat and regain weight.

2.  Our energy burn (called 'energy expenditure') drops - more than we might expect.

Today, we are going to focus on #2 above. (stay tuned for much more on #1 another day!)


So, just how much does our energy burn drop with weight loss?

Well, it turns out that we are geared towards retaining energy and downregulating metabolism in the face of weight loss, as a strong defence mechanism genetically engineered to protect our weight to survive times of famine.  This happens thanks to a decrease in thyroid hormone levels, decrease in sympathetic nervous system tone, an increase in skeletal muscle efficiency, and other changes as well.  While we do expect a proportional decrease in energy burn simply due to the weight loss itself, the decrease in energy burn is actually much more than that, thanks to these changes.


Here's an example: When a person loses 10% of their body weight, one might think that their daily energy burn (called Total Energy Expenditure or TEE) would also drop by 10%, reflecting 10% less body mass that needs daily care and energy, and 10% less body mass for the person to physically carry around in a day.  In fact, studies show that the total energy burn of this person will actually drop by 20-25%, - in other words - to 10-15% less than what would be predicted.

Said another way, it will take 300-400 fewer calories per day to maintain the 10% loss in body weight, compared to a person of the same body shape, size, and weight, who hasn't lost 10% of their weight.

This decrease in total energy expenditure may not persist forever - the POUNDS LOST study suggested that the TEE comes back up to expected baseline after 2 years (though others have suggested that the reduced energy burn lasts as long as 7 years or more).   Some research has also suggested that the drop in energy expenditure may be less with a low carb diet, higher with a low glycemic index diet, and the highest on a low fat diet (my speculation on this is that this may be related to higher protein intake in the low carb diet - it takes more calories to burn and digest protein compared to carbs compared to fat).

Because of this reduction in energy burn with weight loss, as well as the powerful hormone changes that happen to drive hunger, it is very difficult to maintain weight loss.  Fortunately, the American National Weight Control Registry has provided some useful information regarding habits that help keep the weight off (though these are not easy either) - check it out!


Follow me on twitter! @drsuepedersen

www.drsue.ca © 2015 

Read more...

Could A Virus Cause Obesity?

>> Friday, November 20, 2015




Among the numerous complex contributors to obesity, it has long been wondered whether infections, such as viruses, could be a contributor to the obesity epidemic.

In fact, it turns out that a common cold virus, adenovirus-36 (AD-36), has a link with obesity.

Antibodies to AD-36 (showing evidence of previous exposure) have been found in 30% of adults with obesity, compared to only 11% in normal weight adults.  In kids, the story is similar, with 22% of kids with obesity carrying AD-36 antibodies, versus only 7% of kids with normal body weight.

Also interestingly, in parallel with the rise in obesity, AD-36 antibody positivity has increased from 7% in 1992-1998 to 15-20% in 2002-2009.

There are a number of mechanisms by which AD-36 may induce obesity, including:
  • Induction of fat cell formation (in scientific terms: adipogenesis from stem cells via PPAR-gamma signalling pathways)
  • Inflammation induced by the virus (release of inflammatory chemicals has a number of effects on human physiology which contribute to obesity)

Interestingly, while people exposed to AD-36 have a higher rate of obesity, they seem to also be protected from metabolic complications associated with obesity, such as type 2 diabetes and fatty liver.  Mechanisms include: 
  • increased uptake of sugar into cells (increased GLUT4-mediated glucose uptake)
  • an increase in adiponectin, which is an anti-inflammatory hormone made by fat


So, the ultimate success would be if we could vaccinate against AD-36, but also harness its power to decrease the risk of metabolic syndrome.  We are not close to either goal currently, but empowered with this knowledge, research is underway with both of these goals in mind.


Follow me on twitter! @drsuepedersen

www.drsue.ca © 2015 

Read more...

  © Blogger templates Palm by Ourblogtemplates.com 2008

Back to TOP